The comparison of clinical, laboratory, and radiological findings in immunocompromised and immunocompetent patients with COVID‐19: A case‐control study

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) causes coronavirus disease 2019 (COVID‐19) with significant morbidity and mortality. We reported and compared the clinical and para‐clinical findings of immunocompromised and immunocompetent COVID‐19 patients in a case‐control study at the Imam Khomeini hospital in Tehran, Iran.

[1]  Mohammad Safiqul Islam,et al.  A systematic review and meta‐analysis of abnormalities in hematological and biochemical markers among Bangladeshi COVID‐19 cases , 2022, Health science reports.

[2]  Mohammad Safiqul Islam,et al.  Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: A meta-analysis with 55 studies and 10014 cases , 2020, Heliyon.

[3]  A. Rojas-Villarraga,et al.  SARS-CoV-2 (COVID-19) in patients with some degree of immunosuppression , 2020, Reumatología Clínica (English Edition).

[4]  S. Irvani,et al.  Mortality Risk Factors among Hospitalized COVID-19 Patients in a Major Referral Center in Iran. , 2020, The Tohoku journal of experimental medicine.

[5]  P. Gibson,et al.  COVID‐19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre‐COVID‐19 ARDS , 2020, The Medical journal of Australia.

[6]  Z. Ahmadinejad,et al.  Pleural Effusion as a Sign of Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case Report. , 2020, Infectious disorders drug targets.

[7]  Soumitra Sengupta,et al.  Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series , 2020, BMJ.

[8]  R. Fumagalli,et al.  Successful recovery from severe COVID‐19 pneumonia after kidney transplantation: The interplay between immunosuppression and novel therapy including tocilizumab , 2020, Transplant infectious disease : an official journal of the Transplantation Society.

[9]  Raj H. Patel,et al.  COVID‐19 in a patient with HIV infection , 2020, Journal of medical virology.

[10]  C. Gomes,et al.  Immunocompromised patients and coronavirus disease 2019: a review and recommendations for dental health care. , 2020, Brazilian oral research.

[11]  S. S. Alinaghi,et al.  A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case. , 2020, Infectious disorders drug targets.

[12]  J. Fishman.  The Immunocompromised Transplant Recipient and SARS-CoV-2 Infection. , 2020, Journal of the American Society of Nephrology : JASN.

[13]  Bin Liu,et al.  Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China , 2020, European Urology.

[14]  J. Dorward,et al.  Lopinavir/ritonavir: A rapid review of effectiveness in COVID-19 , 2020 .

[15]  Shengyu Zhang,et al.  Novel coronavirus (SARS-CoV-2) infection in a renal transplant recipient: Case report , 2020, American Journal of Transplantation.

[16]  Sapna Shah,et al.  COVID-19 infection in kidney transplant recipients , 2020, Kidney International.

[17]  P. Grossi,et al.  Novel Coronavirus-19 (COVID-19) in the immunocompromised transplant recipient: #Flatteningthecurve , 2020, American Journal of Transplantation.

[18]  L. D’Antiga.  Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic , 2020, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[19]  M. Cascella,et al.  Features, Evaluation and Treatment Coronavirus (COVID-19) , 2020 .

[20]  F. Diekmann,et al.  Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? , 2020, American Journal of Transplantation.

[21]  Yuan Wei,et al.  A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 , 2020, The New England journal of medicine.

[22]  Yuyi Wang,et al.  Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures , 2020, Journal of medical virology.

[23]  Syed Adeel Hassan,et al.  Coronavirus (COVID-19): A Review of Clinical Features, Diagnosis, and Treatment , 2020, Cureus.

[24]  J. Hageman.  The Coronavirus Disease 2019 (COVID-19). , 2020, Pediatric annals.

[25]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[26]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[27]  Jonathan H. Chung,et al.  Essentials for Radiologists on COVID-19: An Update—Radiology Scientific Expert Panel , 2020, Radiology.

[28]  Ying Xuan Chen,et al.  2019 Novel coronavirus infection and gastrointestinal tract , 2020, Journal of digestive diseases.

[29]  Heshui Shi,et al.  Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet Infectious Diseases.

[30]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[31]  Ruchong Chen,et al.  Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China , 2020, The Lancet Oncology.

[32]  J. Kanne,et al.  Chest CT Findings in 2019 Novel Coronavirus (2019-nCoV) Infections from Wuhan, China: Key Points for the Radiologist , 2020, Radiology.

[33]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[34]  P. Ljungman,et al.  Viral Infections in Immunocompromised Patients , 2010, Biology of Blood and Marrow Transplantation.